Mashup Score:65
American College of CardiologyTwitter Feed: American College of Cardiology
Mashup Score:46
CardioSmartAspirin and Heart Disease - 4 days
Mashup Score:46
New – for download only. When should you take daily aspirin? Download the file to print the...
-
Aspirin therapy is not a one-size-fits-all therapy. The 🆕 #CardioSmart Aspirin & #HeartDisease Infographic will help your patients better understand their options & weigh the risk & benefits of #aspirintherapy. https://t.co/RupzKhbslH https://t.co/RupzKhbslH - view on twitter
Mashup Score:38
CardioSmartHigh Blood Pressure – Overview | CardioSmart – American College of Cardiology - 1 week
Mashup Score:38
Did you know that your blood pressure can be a good indicator of your heart’s health?High blood pressure is actually a leading risk factor...
-
Nearly 1 in 2 adults have #hypertension. Our #CardioSmart resources on #highbloodpressure include infographics, fact sheets & an action plan for heart healthier living. Share these resources with your patients for #WorldHypertensionDay! https://t.co/SbZ4RNGQeC https://t.co/SbZ4RNGQeC - view on twitter
Mashup Score:25
American College of CardiologyACC Latin America 2022 Together With CardioAcademic – American College of Cardiology - 5 days
Mashup Score:25
CONFERENCE OVERVIEW MOVE INTO AN ERA OF GLOBAL COLLABORATION The American College of Cardiology and CardioAcademic invite you to join us for an innovative...
-
Deadline approaching to submit abstracts & challenging clinical cases to #ACCLatinAmerica Together with @CardioAcademic! Submission deadline is June 7! Learn more ➡️ https://t.co/soibW2zwJf #ACCIntl #CardioTwitter https://t.co/soibW2zwJf - view on twitter
Mashup Score:25
American College of CardiologyVascular Toxicities of Novel Cancer Therapies – American College of Cardiology - 17 hours
Mashup Score:25
Introduction Numerous types of cancer treatments, ranging from immunotherapy, traditional chemotherapy (e.g., doxorubicin), and targeted therapy (e.g., tyrosine kinase inhibitors [TKIs]) are associated with...
-
Drs. @EvelynSongMD and @baik_alan summarize the common vascular toxicities associated with #cancer therapies and provide a broad overview on their management. Read the expert analysis here: https://t.co/j2pG7FhVwF #NOAC #cvCoag #CardioTwitter https://t.co/j2pG7FhVwF - view on twitter
Mashup Score:22
American College of CardiologyEdoxaban Low-Dose for Elder Care Atrial Fibrillation Patients – American College of Cardiology - 1 day
Mashup Score:22
Dharam J. Kumbhani, MD, SM,...
-
The ELDERCARE-AF trial showed that very low dose edoxaban was superior to placebo in reducing #Stroke or systemic embolism among Japanese #AFib patients ≥80 years of age. Learn more about the clinical trial here: https://t.co/RnushPXVPr #NOAC #cvCoag @DLBHATTMD - view on twitter
Mashup Score:18
American College of CardiologyQuick Takes COVID-19 infection is associated with an increase in the incidence and burden of long-term CVD, including arrythmias, ischemic and non-ischemic heart disease,...
-
#COVID19 infection is associated w/ an increase in the incidence & burden of long-term #CVD, including arrythmias, ischemic & non-ischemic #HeartDisease, myopericarditis, ischemic #stroke, & #cvVTE. https://t.co/yA9mRML1ze @AllisonGHaysMD @DrAnumMinhas @rblument1 @JulieCoursen https://t.co/yA9mRML1ze - view on twitter
Mashup Score:18
American College of CardiologyDharam J. Kumbhani, MD, SM,...
-
The DECLARE–TIMI 58 trial showed that dapagliflozin is superior to placebo in improving glycemic control and noninferior but not superior for reducing MACE in patients with type 2 #diabetes mellitus and high CV risk. Read more: https://t.co/TASf86VDKK @MarcBonaca @keaglemd - view on twitter
More coverage:
#diabetes
Mashup Score:17
American College of CardiologyAnthony A. Bavry, M.D., M.P.H.,...
-
The CORDIOPREV trial showed that a Mediterranean diet was successful at preventing major adverse cardiovascular events. Find out more here: https://t.co/MVqQ3HfoBg #cvSurg #cvCAD #cvPrev @AABavry @DLBHATTMD - view on twitter
Mashup Score:15
American College of CardiologyThe shutdown of a GE manufacturing facility in Shanghai, China, during a COVID-19 lockdown in April has led to a significant shortage of iodinated...
-
💬 By focusing on conserving contrast today, we will hopefully avoid the impact that may limit emergent or urgent care for our patients in the future @Andrea_Price317 Explore the ACC's resource page to help navigate the iodinated contrast media shortage: https://t.co/aS7CM2G1aB https://t.co/aS7CM2G1aB - view on twitter
Dharam J. Kumbhani, MD, SM,...
The REDUCE-IT trial showed that use of IPE 2 g twice daily was superior to placebo in reducing TGs, CV events & CV death among patients w/ high TGs & either known #CVD or those at high risk for developing it. Get the details: https://t.co/BDa2OjrGbH #statin @DLBHATTMD @keaglemd - view on twitter